Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.

It's not the sexiest thing going, but preferred stock, which typically yields between 6% and 9%, can play a beneficial role in income investors' portfolios. As long as those investors know exactly ...

If an event that constitutes a “fundamental change” under the certificate of designations governing the perpetual strife preferred stock occurs, then holders of the perpetual strife preferred ...

MET PRA), subject to the final confirmation that the company has met the financial tests specified in the certificate of designations for the Series A preferred stock, which the company ...

announced on Monday an amendment to its Certificate of Incorporation affecting its Series D Preferred Stock. The amendment, filed on March 31, 2025, removes a provision that could have significant ...

The Evolution of Stock Certificates “Certificates were originally physical documents to show ownership in a company, but now they have transitioned to ...